Cross-reactivity of Haemophilus influenzae type a and b polysaccharides: molecular modeling and conjugate immunogenicity studies
Authors (first, second and last of 6)
Collection
Glycoconjugate vaccines: classic and novel approaches
Glycoconjugate vaccines, obtained by carbohydrates covalently bound to protein carriers, have contributed to fight diseases such as meningitidis, pneumonia and typhoid fever. Despite new technologies such as RNA and adenovirus based vaccine have now reached the market, these approaches are unable to target carbohydrates which are key virulence factors.
This issue intends to provide an overview on relevant directions where the field is evolving and serve as starting point to increase interest in this exciting and fundamental part of vaccinology.
Editors
-
Roberto Adamo
Dr Roberto Adamo is affiliated to: GSK, Via Fiorentina 1, 53100, Siena, Italy, and is interested in the development of carbohydrate-based vaccines and novel therapeutics.
Articles (13 in this collection)
-
-
-
Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates
Authors (first, second and last of 12)
-
Carbohydrate based meningococcal vaccines: past and present overview
Authors (first, second and last of 4)
-
On the use of adenovirus dodecahedron as a carrier for glycoconjugate vaccines
Authors (first, second and last of 10)
-
Correction to: Glyconanoparticles as tools to prevent antimicrobial resistance
Authors (first, second and last of 4)
-
The development and characterization of an E. coli O25B bioconjugate vaccine
Authors (first, second and last of 12)
-
Glyconanoparticles as tools to prevent antimicrobial resistance
Authors (first, second and last of 4)
-
-
-
-
Comparison of polysaccharide glycoconjugates as candidate vaccines to combat Clostridiodes (Clostridium) difficile
Authors (first, second and last of 6)
-
Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM197 as carrier protein
Authors (first, second and last of 4)
